FDAnews Device Daily Bulletin

Industry Should Self-Regulate to Increase Transparency

Oct. 2, 2008
With the credibility of the industry at stake, medical device companies need to proactively approach conflict-of-interest issues to assure lawmakers that transparency is at the forefront of their agendas, industry experts say. “The environment has changed forever, but the change is one we should embrace,” David Dvorak, president and CEO of Zimmer, said at AdvaMed’s 2008 Conference panel discussion on the issue. Panel members agreed that the industry can take a number of steps to lessen the amount of legal restrictions imposed on them.